These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12667595)

  • 1. No success with the SUCCESS trial.
    Cheng TO
    Am J Cardiol; 2003 Apr; 91(7):924. PubMed ID: 12667595
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
    Whelton A; White WB; Bello AE; Puma JA; Fort JG;
    Am J Cardiol; 2002 Nov; 90(9):959-63. PubMed ID: 12398962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis.
    Weaver A; Alderman M; Sperling R
    Am J Cardiol; 2003 May; 91(10):1291-2. PubMed ID: 12745131
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
    Grover SA; Coupal L; Zowall H
    Hypertension; 2005 Jan; 45(1):92-7. PubMed ID: 15545508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celebrex (celecoxib).
    Claussen DW
    Gastroenterol Nurs; 2000; 23(1):43-4. PubMed ID: 11096806
    [No Abstract]   [Full Text] [Related]  

  • 6. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
    Henderson P
    JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939848
    [No Abstract]   [Full Text] [Related]  

  • 7. New drug overview. Celecoxib.
    Am J Health Syst Pharm; 1999 May; 56(10):1031. PubMed ID: 10365731
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis.
    Smith SM; Cooper-DeHoff RM
    Am J Med; 2019 Feb; 132(2):172-174. PubMed ID: 30240679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity.
    Juni P; Sterchi R; Dieppe P
    BMJ; 2003 Feb; 326(7384):334; author reply 334. PubMed ID: 12574052
    [No Abstract]   [Full Text] [Related]  

  • 10. Arthritis supplement combination falls short in study.
    Traynor K
    Am J Health Syst Pharm; 2006 Apr; 63(7):598-600. PubMed ID: 16554274
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.
    Moore RA; Derry S; Makinson GT; McQuay HJ
    Arthritis Res Ther; 2005; 7(3):R644-65. PubMed ID: 15899051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib: a COX-2 inhibitor.
    Andrews SA; Wallace CK; Davis RL
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension associated with therapies to treat arthritis and pain.
    White WB
    Hypertension; 2004 Aug; 44(2):123-4. PubMed ID: 15226278
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
    Scheen AJ
    Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib clinical profile.
    Tive L
    Rheumatology (Oxford); 2000 Dec; 39 Suppl 2():21-8; discussion 57-9. PubMed ID: 11276798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.
    Yelland MJ; Nikles CJ; McNairn N; Del Mar CB; Schluter PJ; Brown RM
    Rheumatology (Oxford); 2007 Jan; 46(1):135-40. PubMed ID: 16777855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib approved as NSAID with some concessions on class warning.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):403. PubMed ID: 10096694
    [No Abstract]   [Full Text] [Related]  

  • 18. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.